EMERGING NON-CLINICAL BIOSTATISTICS IN BIOPHARMACEUTICAL DEVELOPMENT AND MANUFACTURING
ebook

EMERGING NON-CLINICAL BIOSTATISTICS IN BIOPHARMACEUTICAL DEVELOPMENT AND MANUFACTURING (ebook)

HARRY YANG

$1,239.00
IVA incluido
Editorial:
CHAPMAN & HALL
Materia
MEDICINA GRAL
ISBN:
9781315354453
Formato:
Epublication content package
Idioma:
Inglés
DRM
Si

The premise of Quality by Design (QbD) is that the quality of the pharmaceutical product should be based upon a thorough understanding of both the product and the manufacturing process. This state-of-the-art book provides a single source of information on emerging statistical approaches to QbD and risk-based pharmaceutical development. A comprehensive resource, it combines in-depth explanations of advanced statistical methods with real-life case studies that illustrate practical applications of these methods in QbD implementation.

Otros libros del autor

  • DATA SCIENCE, AI, AND MACHINE LEARNING IN DRUG DEVELOPMENT
    HARRY YANG
    The confluence of big data, artificial intelligence (AI), and machine learning (ML) has led to a paradigm shift in how innovative medicines are developed and healthcare delivered. To fully capitalize on these technological advances, it is essential to systematically harness data from diverse sources and leverage digital technologies and advanced analytics to enable data-driven ...

    $1,339.00

  • REAL-WORLD EVIDENCE IN DRUG DEVELOPMENT AND EVALUATION
    HARRY YANG
    Real-world evidence (RWE) has been at the forefront of pharmaceutical innovations. It plays an important role in transforming drug development from a process aimed at meeting regulatory expectations to an operating model that leverages data from disparate sources to aid business, regulatory, and healthcare decision making. Despite its many benefits, there is no single book syst...

    $1,239.00